References
- 1Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v 2.0, cancer incidence and mortality worldwide. 2010;
http://globocan.iarc.fr . Accessed December 12, 2016. - 2Tod M and Meredith WJ. Treatment of cancer of the cervix uteri, a revised Manchester method. Br J Radiol, 1953; 26(305): 252–257. DOI: 10.1259/0007-1285-26-305-252
- 3Wilkinson JM and Ramachandran TP. The ICRU recommendations for reporting intracavitary therapy in gynaecology and the Manchester method of treating cancer of the cervix uteri. Br J Radiol, 1989; 62(736): 362–365. DOI: 10.1259/0007-1285-62-736-362
- 4Grover S, Xu MJ, Yeager A, et al. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol, 2014; 4: 380. DOI: 10.3389/fonc.2014.00380
- 5Teixeira LC. Situation of radiotherapy in Latin America. Int J Radiat Oncol Biol Phys, 1990; 19(5): 1267–1270. DOI: 10.1016/0360-3016(90)90241-B
- 6Zubizarreta EH, Poitevin A and Levin CV. Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). Radiother Oncol, 2004; 73(1): 97–100. DOI: 10.1016/j.radonc.2004.07.022
- 7Einck JP, Hudson A, Shulman AC, et al. Implementation of a high-dose-rate brachytherapy program for carcinoma of the cervix in Senegal: a pragmatic model for the developing world. Int J Radiat Oncol Biol Phys, 2014; 89(3): 462–467. DOI: 10.1016/j.ijrobp.2013.12.008
- 8Efstathiou JA, Bvochora-Nsingo M, Gierga DP, et al. Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnership. Int J Radiat Oncol Biol Phys, 2014; 89(3): 468–475. DOI: 10.1016/j.ijrobp.2014.03.033